USPTO Publishes OWLFY Trademark Application for Opposition

The USPTO has published the trademark application for 'OWLFY' for opposition. The application covers goods including data processing apparatus, microprocessors, and recorded computer software for industrial controllers and data security.

Eubank Music Group Trademark Publication

The USPTO has published the trademark application for Eubank Music Group for opposition. The application covers downloadable music files and entertainment services, including music production and record label services. The filing date was March 22, 2026.

CHUNFUXIN Trademark Application Published for Opposition

The USPTO has published the CHUNFUXIN trademark application for opposition. The application covers various electronic goods, including battery components, chargers, microscopes, and cameras. The publication date is March 23, 2026.

PRAYTIFY Trademark Publication for Opposition

The USPTO has published the PRAYTIFY trademark application for downloadable computer application software for mobile devices. The publication occurred on March 23, 2026, initiating a period for opposition to the trademark registration.

LEARNING EEG Trademark Published for Opposition

The United States Patent and Trademark Office (USPTO) has published the trademark application for "LEARNING EEG" for opposition. The application covers educational services and downloadable software related to electroencephalography (EEG). The publication date is March 23, 2026.

Patent Grant: IGFR-like Receptor Antagonists for Diabetes Treatment

The USPTO has granted a patent (US12583928B2) for novel Insulin-like Growth Factor 1 Receptor (IGFR)-like receptor antagonists and agonists. These compounds are intended for the treatment of diabetes.

USPTO Patent Granted for MUC1 Antibodies for Cancer Treatment

The USPTO has granted patent US12583927B2 to Minerva Biotechnologies Corporation for MUC1 antibodies designed for cancer treatment. The patent covers antibodies that specifically bind to the PSMGFR peptide or its fragments, offering potential new diagnostic and therapeutic applications.

USPTO Patent Grant: Bispecific Antibodies Targeting CD47 and PD-L1

The USPTO has granted patent US12583922B2 for bispecific antibodies targeting CD47 and PD-L1. The patent, assigned to Novimmune SA, covers methods of making and using these antibodies for treating cancers associated with malignant cells expressing CD47 and/or PD-L1.

USPTO Patent Grant: Antibody and CAR Binding to CD70 for Disease Treatment

The USPTO has granted patent US12583931B2 to Nanjing IASO Biotechnology Co., Ltd. for an antibody and chimeric antigen receptor (CAR) that specifically binds to CD70, intended for treating diseases related to CD70 expression. The patent covers the composition of the CAR and its application in disease treatment.

Sri M Prakash vs Sri Praveen Kumar A - Appeal of Civil Suit Dismissal

The Karnataka High Court has issued a judgment in the Regular First Appeal No. 1783 of 2021, concerning the dismissal of a civil suit for declaration and injunction. The appeal challenges the judgment and decree dated July 23, 2021, passed by the City Civil and Sessions Court.